ABIOMED (ABMD), a health care which we tipped as one of our favorites, was hit hard this week, especially today.
The company released earnings today, and fell some 15% during the session, only to recover to a fall of 7% at the close. Is this mini-crash justified or not? In other words, are we looking at a buying opportunity or is this a strong sell?
Let’s first analyze revenues. Below is the overview since the first fiscal quarter of last year:
$73M Q1 FY16
$76M Q2 FY16
$85M Q3 FY16
$93M Q4 FY16
$103M Q1 FY17
$103M Q2 FY17 (quarter ending September 30th of this year)
Now the company’s outlook for FY17 remains at $440M, which implies on average $117M for the next two quarters. That implies a revenue growth of around 14%, which is in line with revenue growth in previous quarters. So that’s an excellent outlook.
From a profitability perspective, the EPS dropped slightly from $0.29 in Q1 FY17 to $0.20 in the latest quarter (EPS was $0.17 in the quarter one year before).
The company is still debt free. The cash position is $236M, up 5% from the previous quarter. There was a slight increase in shares outstanding, slight dilution in other words.
We don’t see any valid reason for concern based on the above data.
Moreover, from a chart perspective, we notice that the stock retraced from a steep rise, only to come to closely to its long term moving average. The stock has seen volatility in the past, so, again, no real reason for concern.
We would say that the $90 level is the key level to watch. We do not expect it will be breached, if so, it would be a very bearish sign. We believe, though, that the decline will not continue, and that the uptrend will continue in the coming weeks. We are not selling our positions at this point, and, depending on price action in the coming days and weeks, would consider an additional position, but only if the decline stops at this level.
Disclaimer: InvestingHaven.com makes every effort to ensure that the information ...
more
Disclaimer: InvestingHaven.com makes every effort to ensure that the information provided is complete, correct, accurate and updated.In spite of these efforts, errors may occur in the information provided.If the information provided contains errors or if certain information is not available on or via the site, InvestingHaven.com will make every effort to rectify the situation as soon as possible. However, InvestingHaven.com cannot be held liable for direct or indirect damages resulting from the use of the information on this site. If you notice any errors in the information provided via the site, please contact the manager of the site.
Moreover, the views expressed in the articles (posts) on this website are the ones from the authors and are for information only. It is not intended as an offer, invitation, or solicitation to buy or sell any of any security or asset described. Nor the website manager nor the authors do accept any liability whatsoever for any direct or consequential loss arising from the use of their content. Please consult a qualified financial advisor before making investments. The information on this website and in the articles (posts) is believed to be reliable , but the authors do not make any representations as to its accuracy or completeness.
The content of the site (including links) may be adjusted, changed or expanded at any time without notice. InvestingHaven.com does not guarantee the proper functioning of the website and cannot be held liable in any way for the improper functioning or temporary (un)availability of the website or for any form of damage, direct or indirect, which may be the result of access to or use of the website.
InvestingHaven.com cannot be held liable under any circumstances by anyone, directly or indirectly, in any specific or other way, for damages resulting from the use of this site or any other site connected by means of links or hyperlinks, including, without limitation, any losses, interruptions of work, damage to programmes or other information on the computer system or to equipment, software or other items owned by the user.
less
How did you like this article? Let us know so we can better customize your reading experience.